Gene: GPR107
Official Full Name: G protein-coupled receptor 107provided by HGNC
Gene Summary: Predicted to enable clathrin heavy chain binding activity. Predicted to be involved in clathrin-dependent endocytosis. Located in Golgi apparatus and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17302 | GPR107 Knockout cell line (HeLa) | Human | GPR107 | 1:3~1:6 | Negative | Online Inquiry |
KO17303 | GPR107 Knockout cell line (HCT 116) | Human | GPR107 | 1:2~1:4 | Negative | Online Inquiry |
KO17304 | GPR107 Knockout cell line (HEK293) | Human | GPR107 | 1:3~1:6 | Negative | Online Inquiry |
KO17305 | GPR107 Knockout cell line (A549) | Human | GPR107 | 1:3~1:4 | Negative | Online Inquiry |
GPR107 Gene Knockout Cell Lines are specialized cellular models that have been genetically modified to render the GPR107 gene nonfunctional, providing a powerful tool for elucidating the role of this receptor in various biological processes. GPR107, a G protein-coupled receptor, has been implicated in several physiological and pathological conditions, including cancer and metabolic disorders. The GPR107 knockout cell lines are created through advanced gene editing technologies, such as CRISPR-Cas9, allowing precise modifications and ensuring the knockout accuracy.
These cell lines facilitate key functions in research by enabling scientists to investigate the downstream effects of GPR107 signaling disruption. Understanding the mechanisms governed by this receptor can lead to breakthroughs in targeted therapies and drug development, particularly for diseases where GPR107 plays a significant role. Additionally, researchers can utilize these knockout lines in phenotypic assays, gene expression analyses, and drug response evaluations, accelerating the pace of discovery in both basic and translational research.
One of the notable advantages of GPR107 Gene Knockout Cell Lines is their specificity. Unlike alternatives that might yield heterogeneous results, these knockout lines provide consistent and reproducible responses, allowing for clearer interpretations of experimental outcomes. Furthermore, as the scientific community increasingly seeks robust models to study gene function, the GPR107 knockout lines are set to become indispensable for researchers focused on receptor biology and therapeutic innovations.
By choosing GPR107 Gene Knockout Cell Lines, researchers gain access to a robust tool that enhances experimental accuracy and relevance. Our company, with a dedicated focus on innovative genetic solutions, is committed to providing high-quality biological products that empower scientific discovery and clinical advancements. Our expertise ensures that researchers and clinicians have the necessary resources to push boundaries in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.